Consequently, our immunohistochemical analyses revealed that FOXM1 expression levels were significantly correlated with Stathmin levels in gastric cancer specimens and both of them were associated with the poor survival as a result of univariate analysis, while only the expression of FOXM1 was identified as an independent prognostic marker for survival duration in post-operational gastric cancer patients, which provided clinical evidence to our mechanism researches. This evidence concerns the gene FOXM1 and gastric cancer.